Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.

IF 3.7 2区 医学 Q1 RHEUMATOLOGY Lupus Science & Medicine Pub Date : 2024-08-03 DOI:10.1136/lupus-2023-001064
Irene Altabás-González, Iñigo Rua-Figueroa, Coral Mouriño, Karen Roberts, Norman Jimenez, Julia Martinez-Barrio, María Galindo, Jaime Calvo Alén, Victor Del Campo Pérez, Esther Uriarte Itzazelaia, Eva Tomero, Mercedes Freire-González, Víctor Martínez Taboada, Eva Salgado, Paloma Vela, Antonio Fernandez-Nebro, Alejandro Olivé, Javier Narváez, Raúl Menor-Almagro, Gregorio Santos Soler, José Ángel Hernández-Beriain, Javier Manero, Elena Aurrecoechea, Oihane Ibarguengoitia-Barrena, Carlos Montilla, Gema Bonilla, Vicenç Torrente-Segarra, Ana Paula Cacheda, María Jesús García-Villanueva, Claudia Moriano-Morales, Concepción Fito Manteca, Nuria Lozano-Rivas, Cristina Bohórquez, José M Pego-Reigosa
{"title":"Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.","authors":"Irene Altabás-González, Iñigo Rua-Figueroa, Coral Mouriño, Karen Roberts, Norman Jimenez, Julia Martinez-Barrio, María Galindo, Jaime Calvo Alén, Victor Del Campo Pérez, Esther Uriarte Itzazelaia, Eva Tomero, Mercedes Freire-González, Víctor Martínez Taboada, Eva Salgado, Paloma Vela, Antonio Fernandez-Nebro, Alejandro Olivé, Javier Narváez, Raúl Menor-Almagro, Gregorio Santos Soler, José Ángel Hernández-Beriain, Javier Manero, Elena Aurrecoechea, Oihane Ibarguengoitia-Barrena, Carlos Montilla, Gema Bonilla, Vicenç Torrente-Segarra, Ana Paula Cacheda, María Jesús García-Villanueva, Claudia Moriano-Morales, Concepción Fito Manteca, Nuria Lozano-Rivas, Cristina Bohórquez, José M Pego-Reigosa","doi":"10.1136/lupus-2023-001064","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess organ damage, with emphasis on the cardiovascular system, over the different stages of the disease in a large SLE cohort.</p><p><strong>Methods: </strong>Multicentre, longitudinal study of a cohort of 4219 patients with SLE enrolled in the Spanish Society of Rheumatology Lupus Registry. Organ damage was ascertained using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). We longitudinally analysed SDI (globally and for each domain) over time only in the 1274 patients whose dates of damage events had been recorded.</p><p><strong>Results: </strong>During the first year after diagnosis of SLE, 20% of the 1274 patients presented with new damage manifestations. At years 2 and 3, new damage was recorded in 11% and 9% of patients. The annual percentage of patients with new damage after year 5 decreased to 5%. In the first year with the disease, most damage was accumulated in the musculoskeletal, neuropsychiatric and renal systems; in later stages, most damage was in the musculoskeletal, ocular and cardiovascular systems. Considering 'cerebrovascular accident' and 'claudication for 6 months' as cardiovascular items, the cardiovascular system was the second most affected system during the early stages of SLE, with 19% of the patients who presented with damage affected at first year after diagnosis. During the late stages, 20-25% of the patients presenting with new damage did so in this modified cardiovascular domain of the SDI.</p><p><strong>Conclusions: </strong>New damage occurs mainly during the first year following diagnosis of SLE. Cardiovascular damage is relevant in both the early and the late stages of the disease. Strategies to prevent cardiovascular damage should be implemented early after diagnosis of SLE.</p>","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"11 2","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331961/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus Science & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/lupus-2023-001064","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To assess organ damage, with emphasis on the cardiovascular system, over the different stages of the disease in a large SLE cohort.

Methods: Multicentre, longitudinal study of a cohort of 4219 patients with SLE enrolled in the Spanish Society of Rheumatology Lupus Registry. Organ damage was ascertained using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). We longitudinally analysed SDI (globally and for each domain) over time only in the 1274 patients whose dates of damage events had been recorded.

Results: During the first year after diagnosis of SLE, 20% of the 1274 patients presented with new damage manifestations. At years 2 and 3, new damage was recorded in 11% and 9% of patients. The annual percentage of patients with new damage after year 5 decreased to 5%. In the first year with the disease, most damage was accumulated in the musculoskeletal, neuropsychiatric and renal systems; in later stages, most damage was in the musculoskeletal, ocular and cardiovascular systems. Considering 'cerebrovascular accident' and 'claudication for 6 months' as cardiovascular items, the cardiovascular system was the second most affected system during the early stages of SLE, with 19% of the patients who presented with damage affected at first year after diagnosis. During the late stages, 20-25% of the patients presenting with new damage did so in this modified cardiovascular domain of the SDI.

Conclusions: New damage occurs mainly during the first year following diagnosis of SLE. Cardiovascular damage is relevant in both the early and the late stages of the disease. Strategies to prevent cardiovascular damage should be implemented early after diagnosis of SLE.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
西班牙风湿病学会红斑狼疮登记处(RELESSER)大型系统性红斑狼疮队列中的损害,重点是心血管系统:纵向分析。
目的评估大量系统性红斑狼疮患者在疾病不同阶段的器官损伤情况,重点是心血管系统:方法:对西班牙风湿病学会狼疮登记处登记的 4219 名系统性红斑狼疮患者进行多中心纵向研究。使用系统性红斑狼疮国际合作诊所/美国风湿病学会损伤指数(SDI)确定器官损伤情况。我们仅对有损害事件发生日期记录的1274名患者的SDI(总体和各领域)进行了纵向分析:结果:在确诊系统性红斑狼疮后的第一年,1274 名患者中有 20% 出现了新的损害表现。在第二年和第三年,分别有11%和9%的患者出现新的损害。第5年后,每年出现新损害的患者比例降至5%。在患病的第一年,大部分损害累积在肌肉骨骼、神经精神和肾脏系统;在后期,大部分损害累积在肌肉骨骼、眼部和心血管系统。将 "脑血管意外 "和 "跛行 6 个月 "作为心血管项目,在系统性红斑狼疮的早期阶段,心血管系统是第二大受影响的系统,有 19% 的患者在确诊后第一年就出现了心血管系统损害。在晚期阶段,20%-25%的患者出现新的损害,都是在SDI的这一修改后的心血管领域:结论:新的损害主要发生在系统性红斑狼疮确诊后的第一年。结论:新的损害主要发生在系统性红斑狼疮确诊后的第一年,心血管损害在疾病的早期和晚期都会出现。在确诊系统性红斑狼疮后,应尽早实施预防心血管损害的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lupus Science & Medicine
Lupus Science & Medicine RHEUMATOLOGY-
CiteScore
5.30
自引率
7.70%
发文量
88
审稿时长
15 weeks
期刊介绍: Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
期刊最新文献
Altered structural and functional homotopic connectivity associated with cognitive changes in SLE. Evaluation and randomised controlled trial of home urinalysis testing in patients with SLE at elevated risk for developing lupus nephritis: a study protocol. Development of a predictive model for systemic lupus erythematosus incidence risk based on environmental exposure factors. Myocardial Performance Index to assess cardiac function in autoimmune connective tissue disease: a systematic review and meta-analysis. Role of intravenous immunoglobulins in the management of systemic lupus erythematosus: a single-centre experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1